Last reviewed · How we verify

NCT04297514: REHABGENRE

Effects of Respiratory Rehabilitation by Gender in COPD Patients

Completed Last updated 9 August 2024
What this trial tests

trial in COPD in 504 participants. Completed in 1 February 2023.

Timeline
1 July 2020
Primary endpoint
1 July 2020
1 February 2023

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusCompleted
Study typeOBSERVATIONAL
Enrollment504
Start date1 July 2020
Primary completion1 July 2020
Estimated completion1 February 2023
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with COPD or Pulmonary Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Without calling into question the effectiveness of pulmonary rehabilitation in women, the difference in outcome by gender was not established due to insufficient evidence . Studies demonstrating the effectiveness of pulmonary rehabilitation include a majority of men, which no longer corresponds to the sex ratio of the disease. The impact of gender on pulmonary rehabilitation outcomes was not established due to insufficient evidence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04297514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing